Showing results (71-80 of 221) with videos related to
Sort By:
Pageof 23
Experimental and Molecular Pathology|August 6, 2010
Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2)Massimo Santoro, Anna Modoni, Marcella Masciullo, et al.Molecular Endocrinology (Baltimore, Md.)|August 6, 2011
A TSH-CREB1-microRNA loop is required for thyroid cell growthVincenza Leone, Daniela D'Angelo, Angelo Ferraro, et al.Cancer Research|January 25, 2012
CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cellsValentina De Falco, Anna Tamburrino, Simona Ventre, et al.European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutationsGiuliana Salvatore, Gennaro Chiappetta, Yuri E Nikiforov, et al.Journal of the Neurological Sciences|July 19, 2017
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patientsMassimo Santoro, Massimiliano Mirabella, Chiara De Fino, et al.Cancer Research|December 20, 2007
Cytosolic phospholipase A2 alpha regulates cell growth in RET/PTC-transformed thyroid cellsStefania Mariggiò, Beatrice Maria Filippi, Cristiano Iurisci, et al.Scientific Reports|November 25, 2025
Discovery of a Proteolysis Targeting Chimera for TRKA and RET-derived oncoproteinsMarialuisa Moccia, Lingzhi Zhang, Zhengyu Wang, et al.The Journal of Clinical Endocrinology and Metabolism|August 14, 2008
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinomaValentina De Falco, Riccardo Giannini, Anna Tamburrino, et al.The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2)Francesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.Cancer Research|February 28, 2002
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenesFrancesca Carlomagno, Donata Vitagliano, Teresa Guida, et al.Pageof 23